Free Trial

Axsome Therapeutics (AXSM) Short Interest Ratio & Short Volume

Axsome Therapeutics logo
$94.60 -0.86 (-0.90%)
(As of 11/20/2024 ET)

Axsome Therapeutics Short Interest Data

Axsome Therapeutics (AXSM) has a short interest of 7.58 million shares. This marks a 0.80% increase in short interest from the previous month. The short interest ratio (days to cover) is 18.4, indicating that it would take 18.4 days of the average trading volume of 620,052 shares to cover all short positions.

Current Short Interest
7,580,000 shares
Previous Short Interest
7,520,000 shares
Change Vs. Previous Month
+0.80%
Dollar Volume Sold Short
$674.85 million
Short Interest Ratio
18.4 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
48,460,000 shares
Percentage of Shares Shorted
15.64%
Today's Trading Volume
380,644 shares
Average Trading Volume
620,052 shares
Today's Volume Vs. Average
61%
Short Selling Axsome Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Axsome Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

AXSM Short Interest Over Time

AXSM Days to Cover Over Time

AXSM Percentage of Float Shorted Over Time

Axsome Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/20247,580,000 shares $674.85 million +0.8%N/A18.4 $89.03
10/15/20247,520,000 shares $649.95 million -3.1%N/A17 $86.43
9/30/20247,760,000 shares $697.39 million +1.2%N/A16.1 $89.87
9/15/20247,670,000 shares $718.45 million +0.8%N/A14 $93.67
8/31/20247,610,000 shares $676.22 million -0.8%N/A11.9 $88.86
8/15/20247,670,000 shares $656.63 million -5.8%N/A11.8 $85.61
7/31/20248,140,000 shares $710.70 million -1.7%N/A12 $87.31
7/15/20248,280,000 shares $685.58 million -3.5%N/A12 $82.80
6/30/20248,580,000 shares $690.69 million -3.5%N/A12.6 $80.50
6/15/20248,890,000 shares $654.57 million +7.5%N/A13.4 $73.63
5/31/20248,270,000 shares $607.27 million +9.0%N/A12.2 $73.43
5/15/20247,590,000 shares $576.31 million -1.6%N/A11.4 $75.93
4/30/20247,710,000 shares $568.69 million -0.5%N/A10.5 $73.76
4/15/20247,750,000 shares $528.63 million +1.3%N/A10.7 $68.21
3/31/20247,650,000 shares $610.47 million +4.8%N/A10.4 $79.80
3/15/20247,300,000 shares $551.44 million -2.3%N/A9.4 $75.54
2/29/20247,470,000 shares $607.91 million -0.7%N/A10.2 $81.38
2/15/20247,520,000 shares $702.82 million +0.4%N/A10.9 $93.46
1/31/20247,490,000 shares $674.32 million -10.0%N/A11.5 $90.03
1/15/20248,320,000 shares $708.95 million -1.2%N/A11.9 $85.21
12/31/20238,420,000 shares $670.15 million +0.7%N/A12.4 $79.59
12/15/20238,360,000 shares $610.20 million -1.1%N/A12.6 $72.99
11/30/20238,450,000 shares $569.95 million +10.6%N/A12.3 $67.45
11/15/20237,640,000 shares $460.00 million +4.0%N/A11.5 $60.21
10/31/20237,350,000 shares $457.76 million -3.2%N/A11 $62.28
10/15/20237,590,000 shares $504.51 million +1.6%N/A10.9 $66.47
9/30/20237,470,000 shares $522.08 million -8.0%N/A10.4 $69.89
9/15/20238,120,000 shares $611.11 million -1.5%N/A9.6 $75.26
8/31/20238,240,000 shares $665.79 million -3.5%N/A9.3 $80.80
8/15/20238,540,000 shares $609.41 million -5.7%N/A9.4 $71.36
7/31/20239,060,000 shares $710.94 million -2.6%N/A9.6 $78.47
7/15/20239,300,000 shares $684.76 million +1.8%N/A10.5 $73.63
6/30/20239,140,000 shares $656.80 million +17.8%24.5%10.1 $71.86
6/15/20237,760,000 shares $656.73 million +0.3%22.2%9.9 $84.63
5/31/20237,740,000 shares $571.06 million +0.9%22.2%9.9 $73.78
5/15/20237,670,000 shares $596.50 million -4.0%22.0%9.1 $77.77
4/30/20237,990,000 shares $571.52 million +1.9%23.3%8.9 $71.53
4/15/20237,840,000 shares $537.04 million -4.5%22.8%8.6 $68.50
3/31/20238,210,000 shares $506.39 million -3.8%23.9%8.7 $61.68
3/15/20238,530,000 shares $528.26 million +1.6%24.8%8.9 $61.93
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

2/28/20238,400,000 shares $572.80 million +4.4%24.5%8.5 $68.19
2/15/20238,050,000 shares $508.28 million +5.4%23.5%6.9 $63.14
1/31/20237,640,000 shares $573 million -3.8%21.6%6.2 $75.00
1/15/20237,940,000 shares $534.36 million +5.2%22.4%5.9 $67.30
12/30/20227,550,000 shares $582.33 million +2.4%21.3%5.4 $77.13
12/15/20227,370,000 shares $570.88 million -7.1%20.8%5.1 $77.46
11/30/20227,930,000 shares $573.26 million +16.8%22.8%5.3 $72.29
11/15/20226,790,000 shares $372.91 million +9.0%19.5%5.2 $54.92
10/31/20226,230,000 shares $281.28 million +8.5%19.3%3.6 $45.15
10/15/20225,740,000 shares $275.52 million +2.5%17.8%3.7 $48.00
9/30/20225,600,000 shares $249.87 million -1.8%17.4%3.8 $44.62
9/15/20225,700,000 shares $351.63 million -3.7%17.7%2.9 $61.69
8/31/20225,920,000 shares $377.70 million +8.4%18.5%3.1 $63.80
8/15/20225,460,000 shares $258.64 million -5.0%17.1%3 $47.37
7/31/20225,750,000 shares $221.89 million -3.9%18.7%4.2 $38.59
7/15/20225,980,000 shares $261.27 million +7.4%19.5%4.1 $43.69
6/30/20225,570,000 shares $213.33 million +6.5%18.1%3.4 $38.30
6/15/20225,230,000 shares $120.29 million +4.8%17.0%3.6 $23.00
5/31/20224,990,000 shares $124.75 million +2.5%16.3%4.7 $25.00
5/15/20224,870,000 shares $135.87 million +7.7%15.9%4.6 $27.90
4/30/20224,520,000 shares $143.51 million -0.9%14.8%4.3 $31.75
4/15/20224,560,000 shares $168.08 million -4.6%15.0%4.7 $36.86
3/31/20224,780,000 shares $197.84 million +5.8%15.9%6.6 $41.39
3/15/20224,520,000 shares $131.67 million +2.3%15.0%7 $29.13
2/28/20224,420,000 shares $124.25 million +17.6%14.7%7.1 $28.11
2/15/20223,760,000 shares $126.90 million +8.4%12.7%6.3 $33.75
1/31/20223,470,000 shares $95.22 million +4.2%11.8%5.5 $27.44
1/15/20223,330,000 shares $95.24 million -2.9%11.3%5.5 $28.60
12/31/20213,430,000 shares $129.59 million -5.0%11.6%5.4 $37.78
12/15/20213,610,000 shares $118.30 million +2.9%12.2%5 $32.77
11/30/20213,510,000 shares $121.24 million +7.7%11.9%4.2 $34.54
11/15/20213,260,000 shares $125.44 million -2.1%11.0%3.5 $38.48
10/29/20213,330,000 shares $128.21 million -11.4%11.2%2.5 $38.50
10/15/20213,760,000 shares $150.78 million -0.3%12.7%2.6 $40.10
9/30/20213,770,000 shares $124.26 million +12.5%12.7%2.8 $32.96
9/15/20213,350,000 shares $92.86 million -16.5%11.3%2.7 $27.72
8/31/20214,010,000 shares $102.98 million +17.9%13.5%3.5 $25.68
8/13/20213,400,000 shares $77.72 million +15.3%11.5%3.4 $22.86
7/30/20212,950,000 shares $143.34 million +8.5%10.0%4.8 $48.59
7/15/20212,720,000 shares $154.41 million -6.2%9.2%6.9 $56.77
6/30/20212,900,000 shares $195.63 million -12.9%9.8%7.7 $67.46
6/15/20213,330,000 shares $223.81 million -2.1%11.3%8.9 $67.21
5/28/20213,400,000 shares $206.41 million +4.3%11.5%9.2 $60.71
5/14/20213,260,000 shares $195.70 million +5.2%11.0%8.9 $60.03
4/30/20213,100,000 shares $191.52 million +7.3%10.5%8.7 $61.78
4/15/20212,890,000 shares $154.76 million -0.3%9.8%8.7 $53.55
3/31/20212,900,000 shares $162.14 million -8.5%9.9%9.7 $55.91
3/15/20213,170,000 shares $210.77 million -1.3%10.8%10.2 $66.49
2/26/20213,210,000 shares $219.50 million +4.2%10.9%10.2 $68.38
2/12/20213,080,000 shares $227.00 million -8.6%10.5%10 $73.70
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

1/29/20213,370,000 shares $235.36 million +0.6%11.5%10.7 $69.84
1/15/20213,350,000 shares $267.63 million -3.2%11.4%10.7 $79.89
12/31/20203,460,000 shares $288.08 million +2.4%11.8%11.4 $83.26
12/15/20203,380,000 shares $270.23 million +1.2%11.5%10.7 $79.95
11/30/20203,340,000 shares $251.10 million -3.5%11.4%9.3 $75.18
11/15/20203,460,000 shares $256.66 million +0.3%11.8%9.5 $74.18
10/30/20203,450,000 shares $234.70 million -4.7%11.8%9.3 $68.03
10/15/20203,620,000 shares $270.16 million -5.2%12.4%9.4 $74.63
9/30/20203,820,000 shares $272.18 million +4.1%13.1%9.4 $71.25
9/15/20203,670,000 shares $298.22 million -4.4%12.6%7.8 $81.26
8/31/20203,840,000 shares $281.51 million -1.0%13.1%8.4 $73.31
8/14/20203,880,000 shares $306.52 million +0.3%13.3%8.1 $79.00
7/31/20203,870,000 shares $276.05 million No Change13.5%7.3 $71.33
7/15/20203,870,000 shares $307.36 million +0.3%13.5%5.7 $79.42
6/30/20203,860,000 shares $317.60 million +9.0%13.4%5.1 $82.28
6/15/20203,540,000 shares $255.84 million +4.1%12.3%4.3 $72.27
5/29/20203,400,000 shares $261.73 million -0.9%11.8%3.5 $76.98
5/15/20203,430,000 shares $298.00 million -4.5%11.9%3.4 $86.88
4/30/20203,590,000 shares $341.16 million -14.9%12.5%3.6 $95.03
4/15/20204,220,000 shares $271.89 million +8.5%14.6%4.8 $64.43
3/31/20203,890,000 shares $297.20 million -6.5%13.5%4.4 $76.40
3/13/20204,158,800 shares $233.52 million +10.0%20.1%5.5 $56.15
2/28/20203,780,000 shares $241.58 million -4.1%18.2%3.3 $63.91
2/14/20203,940,000 shares $305.39 million -3.0%13.8%3.2 $77.51
1/31/20204,060,000 shares $340.31 million +1.8%14.2%3.1 $83.82
1/15/20203,990,000 shares $370.27 million -20.7%13.9%3 $92.80
12/31/20195,030,000 shares $428.56 million -6.0%17.6%3.7 $85.20

AXSM Short Interest - Frequently Asked Questions

What is Axsome Therapeutics' current short interest?

Short interest is the volume of Axsome Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 7,580,000 shares of AXSM short. Learn More on Axsome Therapeutics' current short interest.

What is a good short interest ratio for Axsome Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AXSM shares currently have a short interest ratio of 18.0. Learn More on Axsome Therapeutics's short interest ratio.

Which institutional investors are shorting Axsome Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Axsome Therapeutics: Jane Street Group LLC, Wolverine Trading LLC, Point72 Asset Management L.P., Walleye Trading LLC, Walleye Capital LLC, and SpiderRock Advisors LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Axsome Therapeutics' short interest increasing or decreasing?

Axsome Therapeutics saw a increase in short interest in October. As of October 31st, there was short interest totaling 7,580,000 shares, an increase of 0.8% from the previous total of 7,520,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Axsome Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Axsome Therapeutics: Harmony Biosciences Holdings, Inc. (15.15%), Xencor, Inc. (7.16%), Taro Pharmaceutical Industries Ltd. (0.85%), United Therapeutics Co. (5.24%), Viatris Inc. (2.09%), Royalty Pharma plc (3.84%), Summit Therapeutics Inc. (2.31%), Genmab A/S (0.37%), Insmed Incorporated (7.74%), Dr. Reddy's Laboratories Limited (1.28%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Axsome Therapeutics stock?

Short selling AXSM is an investing strategy that aims to generate trading profit from Axsome Therapeutics as its price is falling. AXSM shares are trading down $0.86 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Axsome Therapeutics?

A short squeeze for Axsome Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AXSM, which in turn drives the price of the stock up even further.

How often is Axsome Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AXSM, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:AXSM) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners